全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Which Gastric Microbiota Associated with H. pylori in Dyspeptic Patients with Gastritis

DOI: 10.4236/ojgas.2018.812044, PP. 425-433

Keywords: Dyspepsia, H. pylori, Microbiota, Histopathology

Full-Text   Cite this paper   Add to My Lib

Abstract:

Introduction: H. pylori is the comment infection worldwide. Its relation to dyspepsia has long been investigated. However, the association between H. pylori and other microbiota in the context of dyspepsia is less understood. The aim of this study was to determine different bacterial species isolated from the stomachs of patients with H. pylori infection and dyspepsia. Methods: A total of 81 patients were included and divided into: group I (N = 50) patients complaining of chronic dyspepsia and group II (N = 31) are patients with non-dyspeptic symptoms endoscoped for reasons other than dyspepsia. All patients were endoscoped and 4 gastric biopsies were obtained from each patient. All patients were examined initially by rapid urease test then histopathology to confirm H. pylori infection and determine the degree of gastric inflammation and finally tissue cultures for H. pylori and other bacterial species using matrix-assisted laser desorption ionization-time-of-flight mass spectroscopy (MALDI-TOF MS). Results: Regarding the demographics; patients of dyspepsia in group I were more consumers of spicy food and smoking than non-dyspeptic patients. Almost, all dyspeptic patients (98%) who had underlying gastric pathology with active gastritis and erosions were the most frequent reported pathological findings. Culture results showed significant association of Staphyloccus and Lactobacillus with dyspepsia while Streptoccous and Klebsilla were more frequent among non-dyspeptic patients. Conclusion: Dyspeptic patients in this study had different grades of gastric pathology and different species of microbiota were isolated, which seems to have concomitant interaction with H. pylori in pathogenicity of gastric mucosa and cause symptoms of chronic dyspepsia.

References

[1]  Sheh, A. and Fox, J.G. (2013) The Role of the Gastrointestinal Microbiome in Helicobacter pylori Pathogenesis. Gut Microbes, 4, 505-531.
https://doi.org/10.4161/gmic.26205
[2]  Schwabe, R.F. and Jobin, C. (2013) The Microbiome and Cancer. Nature Reviews Cancer, 13, 800-812.
https://doi.org/10.1038/nrc3610
[3]  Yang, I., Nell, S. and Suerbaum, S. (2013) Survival in Hostile Territory: The Microbiota of the Stomach. FEMS Microbiology Reviews, 37, 736-761.
https://doi.org/10.1111/1574-6976.12027
[4]  Zilberstein, B., et al. (2007) Digestive Tract Microbiota in Healthy Volunteers. Clinics (Sao Paulo), 62, 47-54.
https://doi.org/10.1590/S1807-59322007000100008
[5]  Maldonado-Contreras, A., Goldfarb, K.C., Godoy-Vitorino, F., Karaoz, U., Contreras, M., Blaser, M.J., et al. (2011) Structure of the Human Gastric Bacterial Community in Relation to Helicobacter pylori Status. The ISME Journal, 5, 574-579.
https://doi.org/10.1038/ismej.2010.149
[6]  Clark, A.E., Kaleta, E.J., Arora, A. and Wolk, D.M. (2013) Matrix-Assisted Laser Desorption Ionization—Time of Flight Mass Spectrometry: A Fundamental Shift in the Routine Practice of Clinical Microbiology. Clinical Microbiology Reviews, 26, 547-603.
https://doi.org/10.1128/CMR.00072-12
[7]  Price, A.B. (1991) The Sidney System: Histological Division. Journal of Gastroenterology and Hepatology, 6, 209-222.
https://doi.org/10.1111/j.1440-1746.1991.tb01468.x
[8]  Pereira, V., Abraham, P., Nallapeta, S. and Shetty, A. (2018) Gastric Bacterial Flora in Patients Harbouring Helicobacter pylori with or without Chronic Dyspepsia: Analysis with Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectroscopy. BMC Gastroenterology, 18, 20.
https://doi.org/10.1186/s12876-018-0744-8
[9]  Porte, L., Garcia, P., Braun, S., Ulloa, M.T., Lafourcade, M., Montana, A., et al. (2017) Head-to-Head Comparison of Microflex LT and Vitek MS Systems for Routine Identification of Microorganisms by MALDI-TOF Mass Spectrometry in Chile. PLoS ONE, 12, e0177929.
https://doi.org/10.1371/journal.pone.0177929
[10]  Talley, N.J., Vakil, N.B., Moayyedi, P. (2005) American Gastroenterological Association Technical Review on the Evaluation of Dyspepsia. Gastroenterology, 129, 1756-1780.
https://doi.org/10.1053/j.gastro.2005.09.020
[11]  Williams C, Mccoll, K.E.L. (2006) Review Article: Proton Pump Inhibitors and Bacterial Overgrowth. Alimentary Pharmacology & Therapeutics, 23, 3-10.
https://doi.org/10.1111/j.1365-2036.2006.02707.x
[12]  Bik, E.M., Eckburg, P.B., Gill, S.R., Nelson, K.E., Purdom, E.A., Francois, F., et al. (2006) Molecular Analysis of the Bacterial Microbiota in the Human Stomach. Proceedings of the National Academy of Sciences of the United States of America, 103, 732-737.
https://doi.org/10.1073/pnas.0506655103
[13]  Noto, J.M. and Peek Jr., R.M. (2017) The Gastric Microbiome, Its Interaction with Helicobacter pylori, and Its Potential Role in the Progression to Stomach Cancer. PLOS Pathogens, 13, e1006573.
https://doi.org/10.1371/journal.ppat.1006573
[14]  Alboraie, M. and Elhossary, W. (2018) Helicobacter pylori Infection in Egypt; a Very Common Disease with Low Evidence Based Clinical Practice. Arab Journal of Gastroenterology, 19, 49.
https://doi.org/10.1016/j.ajg.2018.02.009
[15]  Emara, M.H., Salama, R.I. and Salem, A.A. (2017) Demographic, Endoscopic and Histopathologic Features among Stool H. pylori Positive and Stool H. pylori Negative Patients with Dyspepsia. Gastroenterology Research, 10, 305-310.
https://doi.org/10.14740/gr886w
[16]  Correa, P. (1992) Human Gastric Carcinogenesis: A Multistep and Multifactorial Process—First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Research, 52, 6735-6740.
[17]  Ianiro, G., Molina-Infante, J. and Gasbarrini, A. (2015) Gastric Microbiota. Helicobacter, 20, 68-71.
https://doi.org/10.1111/hel.12260
[18]  Emara, M.H., Mohamed, S.Y. and Abdel-Aziz, H.R. (2014) Lactobacillus reuteri in Management of Helicobacter pylori Infection in Dyspeptic Patients: A Double-Blind Placebo-Controlled Randomized Clinical Trial. Therapeutic Advances in Gastroenterology, 7, 4-13.
https://doi.org/10.1177/1756283X13503514

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133